Therapy area
Immunology and transplant
ATC groups L04
- Molecules
- 87
- Current shortages
- 0
Immunosuppressants and immune-modulating biologics used after organ transplant and for autoimmune conditions.
Molecules
87 molecules, most requested first.
- LenalidomideOrphanThalidomide Analog12 presentations6 brandsL04AX04
- TacrolimusOrphanCalcineurin Inhibitor Immunosuppressant21 presentations8 brandsD11AH01
- MycophenolateAntimetabolite Immunosuppressant13 presentations7 brandsL04AA06
- EverolimusOrphanKinase Inhibitor30 presentations7 brandsL01XE10
- AdalimumabOrphanAntibodies32 presentations23 brandsL04AB04
- MethotrexateOrphanFolate Analog Metabolic Inhibitor28 presentations7 brandsL01BA01
- PirfenidoneOrphanPyridone6 presentations4 brandsL04AX05
- TofacitinibJanus Kinase Inhibitor12 presentations3 brandsL04AF01
- PomalidomideOrphanThalidomide Analog8 presentations7 brandsL04AX06
- CyclosporineOrphanCalcineurin Inhibitor Immunosuppressant25 presentations13 brandsL04AD01
- SirolimusOrphanKinase Inhibitor6 presentations4 brandsL04AH01
- UstekinumabOrphanInterleukin-12 Antagonist32 presentations23 brandsL04AC05
- LeflunomideAntirheumatic Agent5 presentations5 brandsL04AK01
- Dimethyl7 presentations6 brandsL04AX07
- TeriflunomidePyrimidine Synthesis Inhibitor4 presentations4 brandsL04AK02
- AzathioprinePurine Antimetabolite8 presentations3 brandsL04AX01
- FingolimodSphingosine 1-phosphate Receptor Modulator3 presentations4 brandsL04AE01
- TocilizumabOrphanInterleukin-6 Receptor Antagonist17 presentations10 brandsL04AC07
- CladribinePurine Antimetabolite4 presentations3 brandsL01BB04
- InfliximabOrphanTumor Necrosis Factor Blocker7 presentations9 brandsL04AB02
- RisankizumabOrphanInterleukin-23 Antagonist6 presentations2 brandsL04AC18
- EmapalumabOrphanInterferon gamma Blocker7 presentations1 brandL04AG09
- SpesolimabOrphanInterleukin-36 Receptor Antagonist6 presentations3 brandsL04AC22
- ApremilastOrphanPhosphodiesterase 4 Inhibitor5 presentations3 brandsL04AA32
- GuselkumabBiologicInterleukin-23 Antagonist3 presentations2 brandsL04AC16
- MirikizumabOrphanInterleukin-23 Antagonist4 presentations2 brandsL04AC
- SecukinumabBiologicInterleukin-17A Antagonist4 presentations2 brandsL04AC10
- BimekizumabBiologic2 presentations2 brandsL04AC
- MepolizumabOrphanInterleukin-5 Antagonist3 presentations2 brandsL04AC06
- SarilumabBiologicInterleukin-6 Receptor Antagonist2 presentations2 brandsL04AC14
- AbataceptOrphanSelective T Cell Costimulation Modulator4 presentations2 brandsL04AA24
- ThalidomideOrphanDecreased Immunologically Active Molecule Activity4 presentations3 brandsL04AX02
- IxekizumabBiologicInterleukin-17A Antagonist3 presentations2 brandsL04AC13
- SiponimodSphingosine 1-phosphate Receptor Modulator3 presentations2 brandsL04
- RozanolixizumabOrphanNeonatal Fc Receptor Blocker4 presentations2 brandsL04AL02
- UpadacitinibOrphanJanus Kinase Inhibitor4 presentations2 brandsL04AA44
- GolimumabOrphanTumor Necrosis Factor Blocker3 presentations5 brandsL04AB06
- OzanimodSphingosine 1-phosphate Receptor Modulator3 presentations4 brandsL04AA38
- BelimumabBiologicB Lymphocyte Stimulator-specific Inhibitor2 presentations2 brandsL04AG04
- EtanerceptOrphanTumor Necrosis Factor Blocker2 presentations6 brandsL04AB01
- PonesimodSphingosine 1-phosphate Receptor Modulator2 presentations2 brandsL04AE04
- BaricitinibJanus Kinase Inhibitor3 presentations2 brandsL04AF02
- EculizumabOrphanComplement Inhibitor3 presentations6 brandsL04AJ01
- VedolizumabBiologicIntegrin Receptor Antagonist3 presentations3 brandsL04AA33
- ZilucoplanOrphanComplement Inhibitor3 presentations2 brandsL04AJ06
- Certolizumab pegolBiologicTumor Necrosis Factor Blocker2 presentations2 brandsL04AB05
- AlemtuzumabOrphanCD52-directed Cytolytic Antibody2 presentations3 brandsL01XC04
- AnifrolumabBiologicType I Interferon Receptor Antagonist2 presentations2 brandsL04AG11
- PegcetacoplanOrphanComplement Inhibitor2 presentations3 brandsL04AJ03
- SatralizumabOrphan2 presentations2 brandsL04AC
- DanicopanOrphanComplement Factor D Inhibitor2 presentations2 brandsL04AJ09
- Mycophenolic acidAntimetabolite Immunosuppressant2 presentationsL04AA06
- NatalizumabBiologicIntegrin Receptor Antagonist2 presentations3 brandsL03AD
- NerandomilastOrphan2 presentations2 brandsL04AA61
- NipocalimabOrphan2 presentations2 brandsL04AL03
- RavulizumabOrphanComplement Inhibitor2 presentations2 brandsL04AA43
- SiltuximabOrphanInterleukin-6 Antagonist2 presentations2 brandsL04AC11
- TildrakizumabBiologicInterleukin-23 Antagonist2 presentations2 brandsL04AC17
- AnakinraOrphanInterleukin-1 Receptor Antagonist1 presentation1 brandL04AC03
- AvacopanOrphanComplement 5a Receptor Antagonist1 presentation1 brandL04
- BasiliximabOrphanInterleukin-2 Receptor Blocking Antibody1 presentation2 brandsL04AC02
- Icotrokinra1 presentation2 brandsL04AC28
- RilonaceptOrphan1 presentation1 brandL04AC04
- RitlecitinibKinase Inhibitor1 presentation2 brandsL04AF08
- BelataceptOrphanSelective T Cell Costimulation Blocker1 presentation2 brandsL04AA28
- BelumosudilOrphan1 presentation2 brandsL04AA48
- BrodalumabBiologicAntibodies1 presentation2 brandsL04AC12
- CanakinumabOrphan1 presentation2 brandsL04AC08
- CrovalimabOrphanComplement C5 Inhibitor1 presentation2 brandsL04AJ07
- DeucravacitinibTyrosine Kinase 2 Inhibitor1 presentation2 brandsL04AF07
- Diroximel1 presentation2 brandsL04AX07
- Efgartigimod alfaOrphanNeonatal Fc Receptor Blocker1 presentation1 brandL04AA58
- EtrasimodSphingosine 1-phosphate Receptor Modulator1 presentation2 brandsL04AE05
- InebilizumabOrphanCD19-directed Cytolytic Antibody1 presentation2 brandsL04AA
- IptacopanOrphanComplement Factor B Inhibitor1 presentation2 brandsL04A
- OcrelizumabBiologicAntibodies1 presentation2 brandsL04AG08
- OfatumumabOrphanCD20-directed Cytolytic Antibody1 presentation2 brandsL01FA02
- RemibrutinibKinase Inhibitor1 presentation2 brandsL04AA60
- SutimlimabOrphanClassical Complement Pathway Inhibitor1 presentation1 brandL04AJ04
- TeprotumumabOrphanInsulin-like Growth Factor-1 Receptor Inhibitor1 presentation2 brandsL04AG13
- UblituximabBiologicCD20-directed Cytolytic Antibody1 presentation2 brandsL04
- VoclosporinCalcineurin Inhibitor Immunosuppressant1 presentation2 brandsL04AD03
- Filgotinib1 brandL04AF04
- ImlifidaseOrphan1 brandL04AA
- Tegomil1 brandL04AX10
- Tolebrutinib1 brandL04AA62
- Vilobelimab1 brandL04AJ10
Conditions
Adult-onset Still's diseaseAlopecia areataAphthous stomatitisArthritisAtypical hemolytic uremic syndromeAutoimmune hepatitisAutosomal dominant familial periodic feverBehçet's diseaseCOVID-19Castleman's diseaseChromosome 5q deletion syndromeChronic recurrent multifocal osteomyelitisChurg-Strauss syndromeColitisCrohn's colitisCrohn's diseaseCutaneous lupus erythematosusErythema nodosumErythema nodosum leprosumErythroblastopeniaFocal segmental glomerulosclerosisGiant cell arteritisGlomerulonephritisGraft-versus-host diseaseGranuloma annulareGuttate psoriasisHemolytic-uremic syndromeHemophagocytic lymphohistiocytosisIgA glomerulonephritisInterstitial lung diseaseKawasaki diseaseLetterer–Siwe diseaseLichen planusLipoid nephrosisLupus nephritisLymphangioleiomyomatosisMembranoproliferative glomerulonephritisMembranous glomerulonephritisMultiple sclerosisMyasthenia gravis
Country notes
Import rules differ by country, for example permits for unregistered medicines or named-patient routes. Each country guide explains who applies, the documents needed and typical timelines.
All import guidesFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Sourcing Immunology and transplant medicines?
Add the molecules you need to one request. We check each country's import rules before we quote.